This paper describes a multiclass semantic segmentation of breast cancer images into the following classes: Tumour, Stroma, Inflammatory, Necrosis and Other. The images were stained with Haematoxilin and Eosin and acquired from the Cancer Genome Atlas through the Breast Cancer Semantic Segmentation Challenge. Over 12,000 patches of data and classes were generated from training images with the use of data augmentation. The segmentation was obtained with a U-Net architecture for which the hyperparameters were explored systematically. Optimal values were obtained with batch size = 8, Loss function Adam and 50 epochs, which took over 50 hours to train. Due to this fact and limitations in time, the rest of the parameters were explored with 10 epochs and we speculate that values would increase if 50 epochs would be used. The trained U-Net was applied to unseen images, per-patch and the following metrics were obtained from full scale WSI; Accuracy, Mean Area Under the Curve and Dice Index. No post-processing was applied. The resulting segmentations outperformed the baseline in terms of accuracy for some tissues; Tumour from 0.804 to 0.913, Inflammatory from 0.743 to 0.8364. The data is available from the Grand Challenges website (https://bcsegmentation.grand-challenge.org/) and the code is available from the following GitHub repository https://github.com/mauOrtRuiz/Breast_Cancer_Sem_Seg

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Data in this study was obtained from the Breast Cancer semantic segmentation Challenge (BCSS) https://bcsegmentation.grand-challenge.org

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes